Trial · NCT06556719
Registered outcomes16
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 16 of 16
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Feasibility of Intervention Measure (FIM) | Measured at week 0 and week 6 | How feasible the intervention was from the perspective of the participants. This is measured through questionnaire. |
| Primary | Acceptability of Intervention Measure (IAM) | Measured at week 0 and week 6 | How acceptable the intervention is to the participants. This is measured through questionnaire. |
| Primary | Intervention Appropriateness Measure (AIM) | Measured at week 0 and week 6 | How appropriate the intervention is to the participants. This is measured through questionnaire. |
| Secondary | Daily Total Physical Activity of Participants | Week 1 (for 7 days), and week 6 (for 7 days) | Accelerometers (Axivity - AX3 model) will be used to track total daily physical activity |
| Secondary | Heart Rate of Participants | HR will be taken at week 0 and week 6 before and following the 6-minute walk test. | heart rate measured via a blood pressure monitor |
| Secondary | Blood Pressure of Participants | BP will be taken at week 0 and week 6 before and following the 6-minute walk test. | Blood pressure measured via a blood pressure monitor |
| Secondary | Basic Psychological Needs of Participants in Intervention Environment | Assessed at week 0 and week 6 | Basic Psychological Needs and Satisfaction and Frustration scale. This entails feelings/perceptions of autonomy, relatedness, competence, enjoyment, satisfaction, and frustration in the study setting. Higher scores indicate greater satisfaction. |
| Secondary | Physical Literacy of Participants | Assessed at week 0 and week 6 | the Canadian Assessment of Physical Literacy second addition (CAPL-2) will be used. A higher score on the CAPL-2 indicates higher physical literacy. |
| Secondary | Cardiovascular Fitness Levels of Participants | Assessed at week 0 and week 6 | the 6-minute walk test will be used to assess changes in fitness. Greater distance walked in the 6 minute time frame is related to greater levels of cardiovascular fitness. |
| Secondary | Muscular Endurance Levels of Participants | Assessed at week 0 and week 6 | The plank test will be used to assess changes in fitness. The longer the plank is held, the greater the muscular endurance of the participant. |
| Secondary | Daily screen time | Assessed at week 0 and week 6 | data from participants' phone settings will be used to capture daily screen time. Participants will navigate to their screen time settings, where a comprehensive and objective report of their weekly screen time (including average daily screen time) is available. Here, participants will screenshot this data and airdrop it to a secured IU dropbox location. |
| Secondary | Daily social media usage | Assessed at week 0 and week 6 | data from participants' phone settings will be used to capture daily screen time. Participants will navigate to their screen time settings, where a comprehensive and objective report of their weekly screen time (including average daily social media usage) is available. Here, participants will screenshot this data and airdrop it to a secured IU dropbox location. |
| Secondary | Social media addiction | Assessed at week 0 and week 6 | participants will complete the Bergen Social Media Addiction Scale to assess social media addiction. |
| Secondary | Inhibitory control | Assessed at week 0 and week 6 | The Color-Word trial from the Stroop Color and Word Test will be delivered on an iPad/tablet to participants to measure inhibitory control. |
| Secondary | Body Satisfaction | Assessed at week 0 and week 6 | The Body Satisfaction Questionnaire (BSQ) will be completed to assess participants satisfaction of their body shape. |
| Secondary | Body Appreciation | Assessed at week 0 and week 6 | The Body Appreciation Scale (version 2) (BAS-2) will be completed to assess participants' appreciation of their bodies. |
Source ClinicalTrials.govtrials-2026-11-12-0.4.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT06556719/registered